Shenqi Medical's Transjugular Intrahepatic Needle Puncture Device Receives NMPA Approval for Market Launch

Mar 16, 2025 07:30 CST Updated 07:30

Shenqi Medical

Cardiovascular Interventional Device Developer

Shenqi Medical^®Transjugular Intrahepatic Puncture Instrument

Officially Approved for Marketing

Recently, Shanghai Shenqi Medical Technology Co., Ltd. (referred to as "Shenqi Medical")^®"）independently developed by Shanghai Shenqi Medical Technology Co., Ltd."Qi Chuan^®SQ-Surgipath^®Transjugular Intrahepatic Puncture InstrumentOfficially approved for marketing by the National Medical Products Administration (NMPA) (Registration Certificate No. 20253030585).

This device is suitable for transjugular intrahepatic portosystemic shunt (TIPS) procedures via transjugular access to reduce portal vein pressure.

Copyright Statement: This platform aims to help healthcare professionals better understand the latest developments in relevant disease areas. The information published on this platform does not imply agreement with its descriptions or viewpoints, but is merely provided for additional information. If there are any copyright issues, we kindly request the rights holders to contact us, and we will address them as soon as possible. The information is intended solely for healthcare professionals to stay informed, and such information cannot replace professional medical guidance in any way, nor should it be considered as medical advice. If such information is used for purposes other than staying informed, this platform and the author shall not bear any related responsibility.Contact email for cooperation:vascular@edoctor.work。